Clinical Trial Update: Statistical and Epidemiological Study Based on the Use of Convalescent Plasma for the Management of Patients With COVID-19 [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update evaluating convalescent plasma for COVID-19 pneumonia in Phase 1/Phase 2; status not disclosed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• COVID-19 Pneumonia

Drugs mentioned

• Convalescent Plasma (convalescent plasma)

Snippet

Sponsor: Universidad Autonoma de Coahuila | Conditions: COVID-19 Pneumonia, Convalescent Plasma | Phase 1, Phase 2 | Status: UNKNOWN